An electrospun polycaprolactone-collagen membrane for the resurfacing of cartilage defects by Tuan, Barnabas Ho Saey et al.
 
 
 
This is the author version published as: 
 
 
This is the accepted version of this article. To be published as : 
This is the author version published as: 
 
 
 
 
  
 
Catalogue from Homo Faber 2007 
 
 
 
 
 
 
 
 
 
 
 
QUT Digital Repository:  
http://eprints.qut.edu.au/ 
 
Ho, Saey Tuan Barnabas and Ekaputra, Andrew Krishna and Hui, 
James Hoi and Hutmacher, Dietmar W. (2010) An electrospun 
polycaprolactone–collagen membrane for the resurfacing of 
cartilage defects. Polymer International, 59(6). pp. 808‐817. 
           
Copyright 2010 John Wiley & Sons 
For Peer Review
1
An electrospun PCL – collagen membrane for the 
resurfacing of cartilage defects. 
* 1, 2 Saey Tuan Barnabas Ho, 2Andrew Krishna Ekaputra, 1Hoi Po James Hui and  
3Dietmar Werner Hutmacher 
1 Department of Orthopaedic Surgery, Yong Loo Lin School of Medical, National University of Singapore, 
Singapore 119074. 
2 Graduate Programme in Bioengineering, Yong Loo Lin School of Medical, National University of 
Singapore, Singapore 119260. 
3 Regenerative Medicine, Institute of Health and Biomedical Innovation, Queensland University of   
Technology, Australia.   
* Corresponding author. Email g0201956@nus.edu.sg    
Authors’ contacts and mailing details
1. Saey Tuan Barnabas Ho. B.Eng Hons. (Corresponding author) 
 National University of Singapore, DSO Building (Kent Ridge), NUS Tissue 
 Engineering Program (NUSTEP), Level 4, 27 Medicine Drive, Singapore 117510.  
 Fax (65) – 67744082, Email g0201956@nus.edu.sg 
2. Andrew Krishna Ekaputra 
  
 National University of Singapore, DSO Building (Kent Ridge), NUS Tissue 
 Engineering Program (NUSTEP), Level 4, 27 Medicine Drive, Singapore 117510.  
 Fax (65) – 67744082, Email g0300212@nus.edu.sg 
3. Hoi Po James Hui. MBBS FRCS FAMS. 
  
 National University of Singapore, DSO Building (Kent Ridge), NUS Tissue 
 Engineering Program (NUSTEP), Level 4, 27 Medicine Drive, Singapore 117510.  
 Fax (65) – 67744082, Email doshuij@nus.edu.sg 
4. Dietmar Werner Hutmacher. PhD. 
 Regenerative medicine, Institute of Health and Biomedical Innovation, 
 Queensland University of Technology, 60 Musk Avenue, Kelvin Grove QLD 
 4059, Australia, Fax (07)-31386030, Email Dietmar.Hutmacher@qut.edu.au 
Page 1 of 31
http://mc.manuscriptcentral.com/pi-wiley
Polymer International
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
2
Abstract  
A polycaprolactone – collagen electrospun mesh was proposed as a novel alternative to 
the conventional periosteal graft in Autologous Chondrocyte Implantation (ACI). This 
was the first known attempt in designing a cartilage resurfacing membrane by using a 
mechanically resilient Polycaprolactone (PCL) mesh that was enhanced with bioactive 
collagen. PCL – collagen 10, 20 and 40 % electrospun meshes (Coll-10, 20 and 40) were 
evaluated and it was discovered that the collagen retention could only be achieved in Coll-
20 and 40. Furthermore Coll-20 was stiffer and stronger than Coll-40 and it satisfied the 
mechanical demands at the cartilage implant site. When seeded with Mesenchymal Stem 
Cells (MSC), the cells adhered on the surface of the Coll-20 mesh and they remained 
viable over a period of 28 days, however they were unable to infiltrate through the dense 
meshwork. Cell compatibility was also noted in the chondrogenic environment as the 
MSC differentiated into chondrocytes with the expression of Sox9, aggrecan and collagen 
II. More importantly, the mesh did not induce a hypertrophic response from the cells. The 
current findings supported the use of Coll-20 as a cartilage patch and future implantation 
studies are anticipated.          
Keywords : Electrospun Mesh, Polycaprolactone, Collagen and Periosteal Substitute.  
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Introduction 
Progenitor cells are implanted at the osteochondral defect so as to aid tissue regeneration. 
However the full reparative potential can only be realized when the implanted cells are 
retained at the defect site. An autologous periosteal patch is commonly used to achieve 
this goal in ACI procedures as it is readily available and it serves as a source of 
mesenchymal progenitor cells and growth factors which promote cartilage repair 1. 
Unfortunately there are concerns. Gooding et al noted that cartilage hypertrophy occurred 
in a staggering 36.4% f the patients who received periosteal grafts during ACI as 
compared to none with synthetic membranes 2. When the study was repeated in the sheep 
model, the use of the graft resulted in a 45 – 70% increase in the density of the 
subchondral bone 3. This occurred because the periosteal flap stimulated bone remodeling 
and stiffening which would eventually led to the degeneration of the overlying cartilage 
via a build up of stresses. A probable explanation for these occurrences would be the 
expression of Vascular Endothelial Growth Factor (VEGF) by the periosteum. This 
growth factor induces vasculature invasion which encourages bone development 4. In 
view of these concerns, a tissue engineered membrane was being explored as an 
alternative to the periosteal graft. 
The electrospun mesh comprises of minute fibers of nanometer proportions which mimics 
the structural dimensions of naturally occurring Extracellular Matrix (ECM) 5. The 
intricate network of fibers presents a high surface area to volume ratio which enhances 
cellular attachment. These unique topographical details enhanced the attachment and 
survivability of HTB-94 chondrocyte like cell line 6. Interestingly, chondrocytes cultured 
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on PCL electrospun meshes were found to undergo redifferentiation in the absence of 
growth factors, the nanometer topology could have played a significant role 7. In order to 
harness the mechanical stability of synthetic polymers and the bioactivity of natural 
materials, composite meshes are explored. One example would be the blend of poly (L –
lactide – co –  - caprolactone) and collagen I as reported by Kwon et al 8. Compositional 
optimization was required as cell attachment and proliferation improved with the increase 
in the collagen I content but this was offset by a decline in mechanical strength. 
A PCL – collagen I tissue engineered graft was proposed as a membrane covering over 
cartilage defects that were treated with MSC. The electrospun mesh was selected because 
of its porous and permeable architecture which facilitates molecular transport between the 
defect site and the synovial space while preventing the leakage of the implanted MSC. 
Furthermore, the patch would also prevent the opposing articulating surface from coming 
into direct contact with the repair site thereby inflicting abrasive damage on the immature 
cartilaginous tissue. PCL – collagen blends containing 10, 20 and 40% collagen I would 
be evaluated for this application (figure 1). The selection process would be based on their 
collagen retention rates and mechanical properties. MSC – mesh compatibility in an in 
vitro chondrogenic environment was of interest, and it was crucial to screen for tissue 
hypertrophy.  
Experimental 
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Reagents and chemicals
Unless otherwise stated, all reagents used in this study were purchased from Sigma 
Aldrich (St Louis, MO). High glucose Dulbecco’s Modified Eagle’s Medium (high 
glucose DMEM) and low glucose Dulbecco’s Modified Eagle’s Medium (low glucose 
DMEM) were from Gibco BRL (Grand Islands, NY). All labware consumables were 
purchased from Becton-Dickinson (Franklin Lakes, NJ).        
Fabrication of the PCL – Collagen electrospun meshes
PCL collagen composites were prepared by dissolving PCL (Birmingham Polymers, 
Pelham, AL) and bovine collagen type I (Symatase, Chaponost, France) in  1, 1, 1, 3, 3, 3 
fluoro 2-propanol (HFP) (Fluka, Buchs, Switzerland). PCL and collagen were mixed in 9 : 
1, 4 : 1 and 3 : 2 ratios in HFP so as to constitute the PCL – collagen 10% (Coll-10), PCL 
– collagen 20% (Coll-20) and PCL – collagen 40% (Coll-40) blends. Each solution was 
loaded into a syringe positioned on a pump and discharged through a metallic needle at a 
flow rate of 0.75 ml / hr at a potential of 10 kV. The resultant meshes were collected onto 
an earthed aluminum foil placed 15 cm below the discharg  point. Once completed, the 
electrospun meshes were dried in a desiccator and sterilized via 70% ethanol treatment 
with UV irradiation.    
Collagen retention analysis
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The presence of collagen in the newly electrospun Coll-10, 20 and 40 meshes was 
validated through immunofluorescent staining against collagen I. The meshes were firstly 
fixed in methanol and blocked with 3% goat serum (Dako, Glostrup, Denmark). This was 
followed by an incubation with a mouse monoclonal antibody against collagen I (Dilution 
factor 1 : 4000) for 16 hours at 4˚C. The samples were washed with 0.05% PBS-Tween 
and visualization was accomplished by using a secondary TRITC conjugated rabbit anti-
mouse Ig antibody (Dako, Glostrup, Denmark, dilution factor 1 : 100). The specimens 
were subsequently washed and dehydrated through an ethanol series before being 
mounted and viewed with an Olympus IX81 confocal microscope (Japan). 
Collagen release was conducted by soaking the 1 x 1 cm2 meshes in 1 ml of PBS over a 
period of 28 days at 37˚C. 5 samples per membrane were evaluated. 100 µl of the solution 
containing the dissolved collagen was extracted per hourly for the initial 6 hours and at 1, 
2, 3, 7, 14, 21 and 28 days. The incubation volume was reconstituted back to 1 ml with the 
addition of 100 µl of fresh PBS after each extraction. Collagen quantification was done in 
accordance to the Micro BCA protein assay kit protocol (Pierce, Rockford, IL).
Tensile test and porosity measurement
Electrospun meshes were stretched to failure on the Intron 4302 (Norwood, MA). The set 
up was equipped with a 10 N load cell and controlled by a Series IX Automated Materials 
Tester software (version 7.43). 35 x 10 mm2 sample strips were used and they were 
preconditioned overnight in 37˚C PBS. The specimens were clamped and stretched at a 
cross head speed of 10 mm / min in a 37˚C PBS bath. Tensile Young’s modulus, ultimate 
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strength and strain were subsequently derived from the stress-strain curves. The Young’s 
modulus was calculated as the slope of the initial linear region of the curve (without the 
toe region), while the ultimate strength and strain were measured at the point of maximum 
stress. 4 samples per mesh were tested and evaluated. In order to measure the porosity of 
the mesh, 1 x 1 cm2 patches were cut and weighted. These samples were cryosectioned 
and the thickness was measured via microscopy. The porosity of the meshes was 
calculated based on the apparent volume (area x thickness), mass, density of PCL (1.11 
g/ml) and collagen (1.41 g/ml) 9.
MSC isolation and expansion
Bone marrow was aseptically aspirated from the iliac crest of a human donor who was 
undergoing elective orthopaedic procedures. Patient consent was granted and the work 
was approved by the Hospital Institutional Review Board. Upon collection, the bone 
marrow was plated out in low glucose DMEM, 10% Fetal Bovine Serum (FBS, 
Invitrogen, Carlsbad, CA) and 100 U/ml Penicillin Streptomycin (Invitrogen, Carlsbad, 
CA) on 75 cm2 flasks and incubated at 37˚C in 5% CO2, 95% air and 99% relative 
humidity. The unattached cells were removed via repeated Phosphate Buffered Saline 
(PBS) washings after 24 hours. The adherent MSC was cultured with media changes on 
every third day. When the cultures were 75% confluent, they were passaged with 0.25% 
trypsin (Invitrogen, Carlsbad, CA). The enzymatic treatment was quenched in the 
presence of FBS and the cells were counted using a hemocytometer. Only passage 3 MSC 
was used in the experiment. 
Cell cultures
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MSC was seeded at 4000 cells / mm2 on one side of the Coll-20 mesh (4 mm diameter) 
and the construct were maintained in a chondrogenic media comprising of 10-7 M 
dexamethasone, 1% ITS+ premix (Biomedical Diagnostics, Ann Arbor, MI), 50 µg/ml 
ascorbic acid, 1 mM sodium pyruvate (Invitrogen, Carlsbad, CA),  4 mM proline, 1% L-
Glutamine (Invitrogen, Carlsbad, CA),  100 U/ml Penicillin-streptomycin (Invitrogen, 
Carlsbad, CA) and high glucose DMEM. Chondrogenic induction was achieved with 10 
ng/ml of Transforming Growth Factor Beta 1 (TGF-1, Peprotech, Rocky hill, NJ) and the 
growth factor was omitted for uninduced samples. These MSC mesh constructs were 
compared against MSC pellet cultures which were kept under similar conditions. Pellet 
cultures were initiated by centrifuging aliquots of 0.25 million cells at 150g for 10 mins in 
15 ml polyprolene conical tubes.  
Spontaneous MSC osteogenic differentiation on the PCL – collagen mesh was also 
evaluated. MSC was seeded at 500 cells / mm2 on one side of the Coll-20 mesh and 
maintained in the MSC expansion media. This was compared against osteogenic induced 
and uninduced plate cultures which were seeded at the same density. Osteogenic induction 
was achieved with 10-8 M dexamethasone, 50 µM ascorbic acid, 10 mM -
glycerophospate, 10% FBS, 100 U/ml Penicillin Streptomycin and high glucose DMEM. 
The uninduced plate cultures were kept in the MSC expansion media.            
Fluorecein Diacetate (FDA) and Propidium Iodide (PI) staining 
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Cell viability on the Coll-20 mesh was evaluated with FDA –PI staining at 7 and 28 days. 
The media was first aspirated from the cultures and the samples were rinsed in PBS before 
being incubated in a 20 µg/ml FDA solution (Invitrogen, Carlsbad, CA) for 15 mins at 
37˚C under dark conditions. The fluorescent dye was aspirated and the samples were 
washed in PBS. This was followed by a second incubation in a 20 µg/ml PI solution 
(Invitrogen, Carlsbad, CA) for 2 mins at room temperature under dark conditions. After 
which the PI solution was aspirated and the samples were washed with PBS before being 
viewed with an Olympus IX81 confocal microscope (Japan).         
Scanning Electron Microscopy (SEM)
The meshes were examined via a Quanta 200F SEM set up (FEI, Hillsboro, Oregon). Prior 
to imaging, the specimens were gold coated for 90 seconds under a 10 mA current by 
using a JFC 1600 auto fine coater (JEOL, Tokyo, Japan). 
Real Time PCR 
Osteogenic and chondrogenic gene expressions in the in vitro cultures were analyzed at 
day 28. The results were either normalized to that of the osteogenic induced plate cultures 
or the chondrogenic induced pellet cultures. RNA was extracted using Trizol (Invitrogen, 
Carlsbad, CA) and RNeasy Mini kit (Qiagen, Chatsworth, CA). Total RNA was measured 
via the NanoDrop (Nanodrop Technologies, Wilmington, DE). Reverse transcription was 
achieved with 100 ng of RNA via the iScriptTM cDNA synthesis kit (Biorad, Hercules, 
CA). Real time PCR was performed using the SYBR green system (7500 real time PCR 
system, ABI, Foster city, CA). Amplifications for the cDNA samples were carried out at 
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50˚C for 2 mins, 95˚C for 10 mins, followed by 40 cycles at 95˚C for 15 seconds and 60 
˚C for a minute. Primer sequences are as shown on table 1. The level of target gene 
expression was normalized to GAPDH and calculated using the 2-Ct method.              
Histology and Immunostaining 
The MSC mesh, plate and pellet cultures were evaluated via histology and 
immunohistochemistry at day 28. All samples were fixed overnight in 10% neutral 
buffered formalin. The MSC mesh constructs were cryosectioned at 5 µm, while the pellet 
cultures were dehydrated, embedded in paraffin with 5 µm sections taken from the center. 
General morphology was observed with Hematoxylin and Eosin (HE) stain. Mineralized 
deposits were stained with von Kossa (counter stained with Alcian blue). 
Immunohistology was conducted using collagen II (Chemicon, Temecula, CA. Dilution 
factor 1 : 500), collagen X (Quartett, Berlin, Germany. Dilution factor 1:25), aggrecan 
(Abcam, Cambridge, MA. Dilution factor 1:100) and Sox 9 (Santa Cruz, Santa Cruz, CA. 
Dilution factor 1:250) primary antibodies. Isotype controls (Dakocytomation, Glostrup, 
Denmark) were included. Endogenous peroxidase was blocked with hydrogen peroxide 
while antigen retrieval was performed by treating the sections with pepsin (Labvision, 
Fremont, CA) for 20 mins. Biotinylated goat anti mouse and rabbit were used as 
secondary antibodies (Labvision, Fremont, CA) for 30 mins reaction at room temperature. 
Streptavidin peroxidase was administered for 45 mins with the use of 3, 3’ 
diaminobenzidine as a chromogenic agent. Counterstaining was done with Gill’s 
hematoxylin, after which the sections were dehydrated before being coverslipped.    
Statistical Analysis
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The results were expressed in mean ± standard deviation and compared using student t-
test. The difference was considered significant when p < 0.05.  
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Results 
The retention of collagen within the composite meshes influences cell response. This 
retention was evaluated via immunostaining and collagen release analysis. 
Immunohistochemistry validated the presence of collagen in the newly fabricated meshes 
and the negative results in Coll-10 (figure 2A - C) indicated a complete loss of collagen. 
This could have occurred during the washing steps of the immunostaining procedure but it 
was averted when the collagen content was above 10%, thus Coll-10 was excluded from 
the following evaluati ns. When the collagen dissolution profile of Coll-20 and 40 were 
compared (figure 2D), the release rate was relatively slow during the initial 6 hours, but 
eventually the meshes lost 8.6 and 18.27 % of the total collagen after 28 days respectively. 
Hence a higher collagen content was accompanied by a greater collagen loss due to the 
high diffusion gradient.  
Biomechanical competence of the electrospun meshes was important as they would be 
implanted at the load bearing regions of the knee joint. Mechanical characterization has 
shown Coll-20 to be stiffer and stronger than Coll-40. However the ultimate strain and 
porosity of the 2 meshes were equivalent (figure 3) and the average pore sizes were of the 
same order of magnitude. The increase in PCL content has not just conferred greater 
mechanical resilience but that has also altered the morphology of the filaments as thick 
and wavy fibers were deposited for Coll-40 as compared to slim and straight Coll-20 
filaments. The mechanical properties of Coll-20 approximated to that of hyaline cartilage 
which has a tensile modulus of 0.2 – 4.98 MPa 10, 11, ultimate strength of 1 – 8 MPa 12 and 
ultimate strain of 15 – 120% 13, 14. The ultimate strength of Coll-20 (0.15 MPa) was below 
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that of cartilage, however that would still suffice given that the maximum applied 
physiological tensile stress to be 0.15 – 0.4 MPa 15.
As Coll-20 excelled over Coll-10 and 40 in terms of collagen retention and mechanical 
competence, it was further screened for MSC compatibility and osteoinductivity. MSC 
remained viable on the Coll-20 mesh under all conditions. From the SEM images, MSC 
was found to reside on the mesh surface for all groups (figure 4). At day 7, the 
chondrogenic induced cells were ball-up as compared to the flatten morphology on the 
uninduced mesh cultures. However at day 28, the uninduced cells also began to display a 
similar rounded morphology. This might be due to the occurrence of partial chondrogenic 
differentiation in the basal chondrogenic media which lacked TGF-1. When the unseeded 
side of the mesh was examined, it was found to be devoid of cells even after 28 days of in 
vitro culturing (figure 4Cand F). Hence the Coll-20 mesh was an effective porous cell 
barrier as the seeded MSC was unable to penetrate through the dense matrix.  
MSC were attached to the surface of the Coll-20 mesh and they did not infiltrate deep into 
the fine network (figure 5). There was an absence of mineralization and hypertrophy in the 
chondrogenic induced, uninduced and normal media cultures. The cells used for this study 
were able to differentiate into osteoblasts as shown by the positive von Kossa Alcian blue 
stain in the osteogenic induced plate cultures (figure 5D). Mineralization was also noted at 
the cell dense areas of the normal media plate cultures (figure 5E). Gene expressions of 
Runx2 and Bone Sialoprotein (BSP) in the normal media mesh cultures were below that 
of the osteogenic induced plate cultures and they were significantly lower than that of the 
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normal media plate cultures. The collagen I gene expression of the mesh cultures was also 
deficient.  
During chondrogenic induction, cell morphologies of the mesh and pellet cultures 
differed. The differentiated MSC formed distinctive chondrocyte lacunes within the 
induced pellets that were surrounded by a dense ECM matrix (figure 6B). Conversely, 
MSC remained as a layer of cells at the top of the Coll-20 mesh. Despite of not having the 
same morphology, cells of both cultures differentiated into chondrocytes as indicated by 
the presence of the chondrogenic markers such as Sox 9, aggrecan and collagen II. 
Furthermore the mesh cultures have a lower tendency to undergo hypertrophy as collagen 
X was not secreted. This was further reinforced by the significantly lower gene 
expressions of collagen I and X (figure 6K and M). The cells cultured on the Coll-20 mesh 
were able to undergo chondrogenic differentiation, but it was not as effective as that in 
pellet cultures as the gene expression of collagen II was severely deficient (figure 6L). 
This might be attributed to the cell – mesh interaction in the in vitro environment.                                            
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Discussion 
The periosteal flap fulfills various biomechanical and biological functions in ACI. Firstly, 
it prevents the leakage of the implanted cells. Moreover the periosteal cells are able to 
stimulate cartilage repair via the secretion of cytokines and they can also differentiate into 
chondroblasts which assist tissue restoration 16. However, the validity of these 
assumptions was tested and it was discovered that the periosteal patch could also provoke 
cartilage hypertrophy through molecular signaling 4. Furthermore Kajitani et al questioned 
the reparative role of the periosteal cells when there was no difference between the 
cartilage defects that were resurfaced with either fresh or frozen periosteum grafts 17. The 
use of the graft was further complicated by its variable quality due to the patient’s age and 
surgical harvesting technique 1, 18. In view of these shortcomings, other alternatives were 
being sought. Unfortunately, there were only a few of available options and one of them is 
the Chondro-gide membrane (Geistlich Biomaterials, Switzerland) which is an acellular 
porcine collagen I / III bilayer mesh 3, 19. Studies on pure collagen patches have found the 
natural material to be mechanically inadequate and its rapid disintegration at the load 
bearing site have resulted in the loss of the transplanted cells 17. Hence the use of synthetic 
polymers was encouraged given their stability and strength. One example would be the 
foam-like polyurethane membrane that was fabricated by Chia et al through a phase 
inversion process 20. But the permeability of the membrane was questioned as the pore 
spaces might not be fully interconnected. In order to address these constraints, the author 
proposed a composite electrospun membrane as a physical barrier over the cartilage 
defect. The mesh consisted of loosely stacked ultra-fine fibers with interconnected pores, 
hence the matrix is highly porous and permeable.  
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Collagen I was selected as the natural biomaterial that would enhance the bioactivity of 
the mesh 21. However this would only occur if collagen was retained in the mesh. When 
Coll-10, 20 and 40 were screened via immunostaining, it was discovered that a complete 
loss of collagen occurred in the Coll-10 during the washing process. This was averted 
when the collagen content was increased to 20 and 40 %. The release kinetics profile over 
a period of 28 days, indicated a loss of 8.6 and 18.27 % of the total collagen content from 
Coll-20 and 40 respectively. This dissolution phenomenon is widely reported for collagen 
based electrospun meshes 22 and when modulated this gradual material loss creates space 
for cell colonization 5, 23.  
The surface of the articular cartilage is lined by a dense acellular network of collagen 
fibers known as the lamina splendens 24, 25. Coll-20 and 40 are morphologically similar to 
this acellular tissue, but gross resemblance must be coupled with mechanical suitability so 
as to achieve biological functionality. Tensile tests have shown Coll-20 to be stronger and 
stiffer than Coll-40. Coll-20 was comparable to hyaline cartilage in terms of the Young’s 
modulus and ultimate strain moreover its tensile strength would suffice under the applied 
physiological tensile load. Porosity could not account for the disparity in the mechanical 
properties of the 2 meshes as they were equally porous. The differential collagen contents 
were the main cause. In the composite blend, collagen existed as a separate phase within 
PCL and the transition zones between the 2 material phases served as stress concentrators 
and fracture points. Therefore an increase in collagen content would inevitably be
accompanied by a decline in physical strength 26.  
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The MSC cultured on Coll-20 were firmly attached on the mesh and they remained viable 
under all conditions. Cell adhesion was promoted by the porous architecture and enhanced 
by the presence of bioactive collagen I. However these attached cells were unable to 
infiltrate through the porous meshwork and colonized the reverse side. The reason was 
because the 8.14 µm pores were too restrictive for cell migration. It was suspected that the 
pore size was indirectly correlated to the diameter of the electrospun fibers. When Shin et 
al experimented with 550 ± 150 nm PLGA electrospun mesh (diameter), he too noted that 
the cells aggregated on the seeded surface and they were unable to infiltrate into the 
constrictive pores channels 27. Li et al was able to prevent this by using larger filaments 
measuring 500 – 900 nm in diameter 28. In this current study, the unique architectural 
features of the Coll-20 mesh not only allowed it to serve as an effective cell barrier but 
also as a permeable membrane that facilitates diffusion from the synovial space. 
The Coll-20 mesh did not elicit any hypertrophic or osteogenic response from MSC, as the 
mesh cultures did not exhibit any overt signs of mineralization. There was a low gene 
expression of collagen I and an absence of Runx2 and BSP in the normal media mesh 
cultures as compared to the normal media plate cultures which registered basal 
expressions of these osteogenic markers. It should be noted that the Coll-20 mesh and 
plate cultures were seeded at the same density with progenitor cells that were capable of 
osteogenic differentiation. Mild mineralization was even noted in the cell dense areas of 
the plate culture but this did not occur on the mesh construct. In the chondrogenic mesh 
cultures, gene expressions of collagen I and X were significantly lower than that of the 
induced pellet. Moreover collagen X was not secreted on the Coll-20 mesh. All these 
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experimental evidences pointed to the inability of Coll-20 to induce tissue hypertrophy 
and this might be attributed to its topographical cues which modulated the cell response.
Cell compatibility on the Coll-20 mesh was observed under chondrogenic induction. The 
seeded MSC differentiated into chondrocytes which exhibited a ball-up morphology, they 
stained positively for Sox9 and aggrecan. Though collagen II was secreted, the gene 
expression was significantly low. This suggested that the chondrogenic differentiation 
might not be as effective as that in the induced pellets. A probable reason would be that 
MSC agglomerate best in a 3D environment before differentiating into chondrocytes 29, 30. 
This was however not the case on the Coll-20 mesh as the cells were firmly attached to the 
surface of the mesh. Such cells could only cluster to a limited extent with those 
surrounding them and as a result the differentiation process was deficient. However this 
limitation was not a major concern as the research objective was to simply design a 
protective cover over the cartilage defect site with cell compatibility in the chondrogenic 
environment. In contrast, Li et al reported of comparable chondrogenic differentiation 
between induced mesh and pellets cultures as the seeded MSC has infiltrated deep into the 
sparse matrix. These progenitor cells agglomerated and differentiated within the 
meshwork and it suited Li et al’s objective of tissue engineering a cartilage implant 31.
PCL was selected as the base material for the patch because it is stable. As the polymer 
degrades slowly, the patch is able to fulfill its protective function over a longer period of 
time at the load bearing site of the knee joint. PCL breaks down via hydrolytic cleavage 
and during a 3 month in vitro degradation study, Chen et al noted an increase in the 
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fractional crystallinity that accompanied the reduction in molecular weight 32. This 
increase in fractional crystallinity was due to polymer recrystallization which in turn 
slowed down the degradation process 33, 34. The break down of the mesh was not just 
dependent on material properties but also on the site of implantation, matrix porosity and 
surface area 27.
This is the first known attempt to the best of the author’s knowledge to harness an 
electrospun mesh as a protective barrier over the cartilage defect. Other applications of the 
ultra fine matrix would include bone, cardiac and dermal regeneration. Shin et al had 
demonstrated the possibility of growing woven bone within a porous PCL mesh that was 
seeded with neonatal rat MSC 35. Cardiomyocytes cultured on electrospun meshes could 
be conditioned to express specific cardiac proteins such as connexin48 and cardiac 
troponin I 36. Venugopal et al on the other hand was able to engineer an electrospun 
dermal graft that has the same mechanical properties as that of native skin 37. These are 
just a few of the potential applications of the electrospun mesh and more is anticipated in 
the near future given its versatility.  
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Conclusion 
PCL – collagen electrospun meshes were evaluated as the cartilage resurfacing membrane 
which might potentially replaced the conventional periosteal flap. Material and 
mechanical considerations have indicated Coll-20 to be mechanically comparable to 
hyaline cartilage while having high collagen retention rate. In vitro studies have 
demonstrated MSC mesh compatibility in the chondrogenic environment as the seeded 
cells were capable of differentiating into chondrocytes but not with the same efficacy as 
that in pellet cultures. But more importantly, the mesh did not induce a hypertrophic or 
osteogenic reaction. The Coll-20 mesh was a permeable membrane that could prevent cell 
leakage as the seeded MSC were unable to migrate through the dense ultra-fine mesh. 
These findings supported the use of Coll-20 as a cartilage patch and future in vivo
evaluations are anticipated. 
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An electrospun PCL – collagen membrane for the resurfacing of 
cartilage defects. 
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Figure 1. Schematic layout of the investigation. 3 compositions of PCL 
collagen electrospun blends were evaluated. They were subjected to 
collagen retention and mechanical assessment. After which the selected 
mesh was seeded with MSC in order to gauge the cell response to the 
synthetic membrane.  
Collagen retention 
Mechanical characterization 
MSC – mesh compatibility 
in the in vitro chondrogenic 
environment  
Screening of hypertrophic 
markers  
Compositions tested 
 
1. PCL – collagen 10% (Coll-10) 
2. PCL – collagen 20% (Coll-20) 
3. PCL – collagen 40% (Coll-40) 
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Figure 2. Collagen retention of the electrospun meshes. Immunofluorescent staining against collagen I in 
the Coll-10 (A), Coll-20 (B) and Coll-40 (C) meshes. Collagen was totally leached out from Coll-10 during 
the preparation for immunostaining hence it was not subjected to any further evaluations. The percentage of 
collagen released was normalized to the initial amount in Coll-20 and 40 (D). The values of Coll-20 and 40 
were significantly different at each time point (p < 0.05). N is 5.    
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Figure 3. Mechanical and architectural properties of Coll-20 and 40 meshes. Tensile Young’s modulus (A), 
ultimate strength (B), strain (C) and porosity (D) are as shown. * indicates significant difference between 
Coll-20 and 40 (p < 0.05). SEM images of Coll-20 (E and F) and Coll-40 (G and H). The Coll-20 fibers were 
slender and straight while those in Coll-40 were thick and wavy. The average pore sizes of Coll-20 and 40 
were 8.14 and 6.42 μm respectively, while the average filament diameters were 430 and 625 nm respectively.     
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Figure 4. Cell viability and morphology during chondrogenic induction. FDA-PI staining and SEM 
imaging at day 7 and 28 for the chondrogenic induced and uninduced MSC seeded Coll-20 meshes. The 
induced samples exhibited a ball-up morphology at the early time point (D) as compared to the uninduced 
cultures which were spread out (I). It was only at day 28, that the uninduced cells were ball-up. No cells 
penetrated to the unseeded side of the Coll-20 mesh as observed on day 28 (C and F). 
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Figure 5. Evaluation of tissue hypertrophy on the Coll-20 mesh.Von Kossa alcian blue staining at day 28 for the 
chondrogenic induced (A) and uninduced (B) MSC mesh constructs. The seeded mesh was also maintained in normal 
media (C). There was a general absence of mineralization as compared to the plate cultures that were kept in osteogenic 
inductive (D) and normal media (E) for 28 days. Mild mineralization occurred in E at the cell dense areas. Real time PCR 
of Runx2 (F), BSP (G) and collagen I (H) of the MSC mesh culture that was maintained in normal media. The results were 
normalized against the osteogenic induced plate cultures. * indicates significant difference between the normal media Coll-
20 and osteogenic induced plate cultures (p < 0.05). # indicates significant difference between the Coll-20 and plate 
cultures maintained in normal media (p < 0.05). N was 4 for each group.   
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Figure 6.  Chondrogenic differentiation of MSC seeded on the electrospun mesh at 28 days. HE (A and B) and 
immunostaining against Sox9 (C and D), aggrecan (E and F), collagen II (G and H) and collagen X (I and J) of the 
chondrogenic induced MSC Coll-20 constructs (A, C, E, G and I) and MSC pellet cultures (B, D, F, H and J). During 
induction, the differentiated MSC formed lacunes in the pellet (B) while they remained as a layer of cells at the top of 
the mesh (A). Sox9 was expressed in the induced mesh samples (C) and this was accompanied by the presence of 
aggrecan (E) and collagen II (G), but not Collagen X (I). Isotype controls and uninduced samples from both groups were 
negatively stained (results not shown). Gene expressions of collagen I (K), II (L) and X (M) at day 28. The results were 
normalized to that of the chondrogenic induced pellets. MSC chondrogenesis on the mesh was not as effective as that in 
pellet cultures. * indicates significant difference between the induced mesh and pellet cultures (p < 0.05). The sample 
size was 4 for each group.   
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Target gene Ascension 
no.  
Forward Reverse Size 
Runx2 NM_004348 5’ – AAC CCA CGA ATG 
CAC TAT CCA – 3’ 
5’ – CGG ACA TAC CGA 
GGG ACA TG – 3’ 
76 bp 
BSP NM_004967 5’ – TGC CTT GAG CCT 
GCT TCC – 3’ 
5’ – GCA AAA TTA AAG 
CAG TCT TCA TTT TG – 3’ 
78 bp 
Collagen I NM_000088 5’ – CAG CCG CTT CAC 
CTA CAG C – 3’ 
5’ – TTT TGT ATT CAA 
TCA CTG TCT TGC C – 3’ 
83 bp 
Collagen II NM_033150 5’- GGC AAT AGC AGG 
TTC ACG TAC A – 3’ 
5’- CGA TAA CAG TCT TGC 
CCC ACT T – 3’ 
79 bp 
Collagen X NM_000493 5’ – CAA GGC ACC ATC 
TCC AGG AA – 3’ 
5’ – AAA GGG TAT TTG 
TGG CAG CAT ATT – 3’ 
70 bp 
GAPDH NM_002046 5’ – ATG GGG AAG GTG 
AAG GTC G – 3’ 
5’ – TAA AAG CAG CCC 
TGG TGA CC – 3’ 
70 bp 
 
Table 1. Real time PCR primer sequences. 
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